S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
3 Oil-And-Gas Stocks Moving Higher Despite Push For Green Energy
It’s Time For A Second Helping Of These Hot Stocks
3 November Winners to Ride in December
MarketBeat vs. TipRanks Comparison
Three IPO’s To Buy In December 
Do You Need a Financial Advisor Before the End of the Year? Here’s How to Know for Sure
Stocks sink on new COVID variant; Dow loses 905 points
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
3 Oil-And-Gas Stocks Moving Higher Despite Push For Green Energy
It’s Time For A Second Helping Of These Hot Stocks
3 November Winners to Ride in December
MarketBeat vs. TipRanks Comparison
Three IPO’s To Buy In December 
Do You Need a Financial Advisor Before the End of the Year? Here’s How to Know for Sure
Stocks sink on new COVID variant; Dow loses 905 points
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
3 Oil-And-Gas Stocks Moving Higher Despite Push For Green Energy
It’s Time For A Second Helping Of These Hot Stocks
3 November Winners to Ride in December
MarketBeat vs. TipRanks Comparison
Three IPO’s To Buy In December 
Do You Need a Financial Advisor Before the End of the Year? Here’s How to Know for Sure
Stocks sink on new COVID variant; Dow loses 905 points
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
3 Oil-And-Gas Stocks Moving Higher Despite Push For Green Energy
It’s Time For A Second Helping Of These Hot Stocks
3 November Winners to Ride in December
MarketBeat vs. TipRanks Comparison
Three IPO’s To Buy In December 
Do You Need a Financial Advisor Before the End of the Year? Here’s How to Know for Sure
Stocks sink on new COVID variant; Dow loses 905 points
OTCMKTS:TMED

Trimedyne Stock Forecast, Price & News

$4.25
0.00 (0.00%)
(As of 03/20/2020)
Add
Compare
Today's Range
$4.25
▼
$4.25
50-Day Range
$4.25
▼
$4.25
52-Week Range
$3.48
▼
$7.00
Volume
110 shs
Average Volume
570 shs
Market Capitalization
$522.75 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive TMED News and Ratings via Email

Sign-up to receive the latest news and ratings for Trimedyne and its competitors with MarketBeat's FREE daily newsletter.


Trimedyne logo

About Trimedyne

Trimedyne, Inc. manufactures and sells lasers, and disposable and reusable fiber-optic laser devices for use in the medical field. It offers lasers, fibers, needles, and switch tips for use in orthopedics, urology, ear and nose surgery, throat surgery, gynecology, gastrointestinal surgery, general surgery, and other medical specialties. The company also provides 80 watt and 30 watt holmium lasers, and side firing laser needles to treat herniated or ruptured spinal discs. In addition, it engages in the provision of services, and rental of lasers and other medical equipment to hospitals and surgery centers on a fee-per-case basis. The company operates in Asia, Europe, Latin America, the Middle East, Australia, and internationally. It markets its products through commission sales representatives in the United States and independent distributors internationally. Trimedyne, Inc. was founded in 1980 and is based in Irvine, California.

Headlines

Analyzing Trimedyne (OTCMKTS:TMED) & Helius Medical Technologies (NASDAQ:HSDT)
November 23, 2021 |  americanbankingnews.com
Comparing Nuwellis (NASDAQ:NUWE) & Trimedyne (OTCMKTS:TMED)
November 6, 2021 |  americanbankingnews.com
EGF Theramed Health Closes Tranche of Financing
June 16, 2020 |  finance.yahoo.com
Trimedyne Reports Its Financial Results for the Quarter Ending on December 31, 2019
February 18, 2020 |  finance.yahoo.com
Trimedyne, Inc. (TMED)
February 10, 2020 |  finance.yahoo.com
Trimedyne, Inc. Reports Its Financial Results for Its Fiscal Year Ending on September 30, 2019
December 20, 2019 |  finance.yahoo.com
Trimedyne Reports Its Financial Results for the...
August 27, 2019 |  www.benzinga.com
Trimedyne Reports Its Financial Results for the Quarter Ended on June 30, 2019
August 27, 2019 |  finance.yahoo.com
Trimedyne Reports Its Financial Results for the Quarter Ending on March 31, 2019
July 24, 2019 |  finance.yahoo.com
Trimedyne Mourns the Death of Marvin P. Loeb
March 26, 2019 |  finance.yahoo.com
Trimedyne Reports Its Financial Results For The Quarter Ending on December 31, 2018
February 11, 2019 |  finance.yahoo.com
Trimedyne Reports Its Financial Results for Its Fiscal Year Ending on September 30, 2018
December 21, 2018 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Computer and Technology
Current Symbol
OTCMKTS:TMED
Previous Symbol
CUSIP
N/A
CIK
357001
Web
www.trimedyne.com
Phone
949-951-3800
Fax
949-855-8206
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Price-To-Earnings

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A

Miscellaneous

Outstanding Shares
123,000
Free Float
N/A
Market Cap
$522.75 thousand
Optionable
Not Optionable

Company Calendar

Last Earnings
2/20/2018
Today
11/27/2021
Fiscal Year End
9/30/2022

MarketRank™

Overall MarketRank™

0.94 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -












Trimedyne (OTCMKTS:TMED) Frequently Asked Questions

How has Trimedyne's stock price been impacted by COVID-19 (Coronavirus)?

Trimedyne's stock was trading at $4.30 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, TMED stock has decreased by 1.2% and is now trading at $4.25.
View which stocks have been most impacted by COVID-19.

How were Trimedyne's earnings last quarter?

Trimedyne, Inc. (OTCMKTS:TMED) announced its earnings results on Tuesday, February, 20th. The technology company reported $0.70 earnings per share for the quarter. The technology company earned $1.53 million during the quarter.
View Trimedyne's earnings history.

Who are Trimedyne's key executives?

Trimedyne's management team includes the following people:
  • Mr. Glenn D. Yeik, Interim Chairman, CEO & Pres (Age 51)
  • Mr. Brian T. Kenney, VP of Global Sales & Marketing (Age 62)

What other stocks do shareholders of Trimedyne own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trimedyne investors own include Aflac (AFL), Diana Shipping (DSX), Cohen & Steers Closed-End Opportunity Fund (FOF), Incyte (INCY), National Fuel Gas (NFG), PDC Energy (PDCE), The Rank Group (RNK), Safehold (SAFE), Snap (SNAP) and Aramark (ARMK).

What is Trimedyne's stock symbol?

Trimedyne trades on the OTCMKTS under the ticker symbol "TMED."

How do I buy shares of Trimedyne?

Shares of TMED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Trimedyne's stock price today?

One share of TMED stock can currently be purchased for approximately $4.25.

How much money does Trimedyne make?

Trimedyne has a market capitalization of $522.75 thousand.

What is Trimedyne's official website?

The official website for Trimedyne is www.trimedyne.com.

Where are Trimedyne's headquarters?

Trimedyne is headquartered at 5 HOLLAND BLDG #223, IRVINE CA, 92618.

How can I contact Trimedyne?

Trimedyne's mailing address is 5 HOLLAND BLDG #223, IRVINE CA, 92618. The technology company can be reached via phone at 949-951-3800 or via fax at 949-855-8206.


This page was last updated on 11/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.